Display options
Cite
Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the Diabetes Quality of Life measure. J Diabetes Investig. 2012;3(5):471-8doi: 10.1111/j.2040-1124.2012.00217.x.
Pakpour, A. H., Saffari, M., & Burri, A. (2012). Translation and validation of an Iranian version of the Diabetes Quality of Life measure. Journal of diabetes investigation, 3(5), 471-8. https://doi.org/10.1111/j.2040-1124.2012.00217.x
Pakpour, Amir H, et al. "Translation and validation of an Iranian version of the Diabetes Quality of Life measure." Journal of diabetes investigation vol. 3,5 (2012): 471-8. doi: https://doi.org/10.1111/j.2040-1124.2012.00217.x
Pakpour AH, Saffari M, Burri A. Translation and validation of an Iranian version of the Diabetes Quality of Life measure. J Diabetes Investig. 2012 Oct 18;3(5):471-8. doi: 10.1111/j.2040-1124.2012.00217.x. PMID: 24843609; PMCID: PMC4019249.
Copy Download .nbib Format: NLM
Share it on

J Diabetes Investig. 2012 Oct 18;3(5):471-8. doi: 10.1111/j.2040-1124.2012.00217.x.

Translation and validation of an Iranian version of the Diabetes Quality of Life measure.

Journal of diabetes investigation

Amir H Pakpour, Mohsen Saffari, Andrea Burri

Affiliations

  1. Qazvin Research Center for Social Determinants of Health ; Department of Public Health, Qazvin University of Medical Sciences, Qazvin.
  2. Department of Health Education, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  3. Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.

PMID: 24843609 PMCID: PMC4019249 DOI: 10.1111/j.2040-1124.2012.00217.x

Abstract

UNLABELLED: Aims/Introduction:  The objective of this study was to translate and validate an Iranian version of the Diabetes Quality of Life (DQOL) questionnaire in an Iranian population of males and females with a diagnosis of type 2 diabetes.

MATERIALS AND METHODS:   A total of 503 patients with type 2 diabetes were recruited from nine diabetes clinics across several Iranian cities. A standard backward and forward translation procedure was used to convert the English version of the DQOL into the Iranian language (Persian). Internal consistency, convergent validity, known group comparison, confirmatory factor analysis (CFA) and factorial invariance were applied for the assessment of psychometric properties of the translated version.

RESULTS:   The translated version of the DQOL showed adequate internal consistency reliabilities for all subscales (Cronbach's α >0.70). CFA confirmed the underlying domain structure to be the same as for the original English version, therefore supporting the factorial validity of the translated questionnaire. In addition, questionnaire responsiveness showed good sensitivity to interventions.

CONCLUSIONS:   In conclusion, the translated Iranian version of DQOL has shown high internal reliability and good construct validity, and can potentially be applied as an assessment tool for health-related quality of life in patients with diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2012.00217.x, 2012).

Keywords: Diabetes Quality of Life; Type 2 diabetes; Validity

References

  1. J Behav Med. 1991 Feb;14(1):43-51 - PubMed
  2. Diabetes Care. 2004 May;27(5):1047-53 - PubMed
  3. Coll Antropol. 2011 Sep;35(3):687-93 - PubMed
  4. Expert Opin Drug Saf. 2011 Mar;10(2):227-38 - PubMed
  5. Diabetes Res Clin Pract. 2008 Jan;79(1):117-23 - PubMed
  6. Qual Life Res. 1997 Jan;6(1):11-20 - PubMed
  7. J Phys Act Health. 2012 Jul;9(5):634-41 - PubMed
  8. N Biotechnol. 2008 Oct-Dec;25(2-3):111-6 - PubMed
  9. Acta Ophthalmol. 2012 May;90(3):237-43 - PubMed
  10. Diabetes Res Clin Pract. 2004 Aug;65(2):105-15 - PubMed
  11. Qual Life Res. 2005 Apr;14(3):875-82 - PubMed
  12. Curationis. 2001 Mar;24(1):74-8 - PubMed
  13. Prev Chronic Dis. 2011 Nov;8(6):A130 - PubMed
  14. Qual Life Res. 2000 Mar;9(2):207-18 - PubMed
  15. Diabetes Care. 2011 Oct;34(10):2244-9 - PubMed
  16. J Diabetes Sci Technol. 2007 May;1(3):394-9 - PubMed
  17. Qual Life Res. 2007 Jun;16(5):873-9 - PubMed
  18. Med Care. 1999 Apr;37(4 Suppl Lilly):AS45-66 - PubMed
  19. BMC Public Health. 2008 May 24;8:176 - PubMed
  20. Diabetes Care. 1996 Mar;19(3):204-10 - PubMed
  21. Eur J Cancer. 2002 Sep;38(14):1824-31 - PubMed
  22. Diabetes Care. 1998 May;21(5):757-69 - PubMed
  23. Diabetes Care. 2002 Mar;25(3):458-63 - PubMed
  24. Diabetes Educ. 2011 Sep-Oct;37(5):689-98 - PubMed
  25. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91 - PubMed
  26. Diabet Med. 1999 Jan;16(1):23-30 - PubMed
  27. Nurs Res Pract. 2011;2011:613589 - PubMed
  28. Psychol Rep. 1966 Aug;19(1):3-11 - PubMed
  29. J Diabetes Complications. 2003 Jan-Feb;17(1):39-58 - PubMed
  30. Br J Ophthalmol. 2012 Feb;96(2):156-61 - PubMed
  31. Diabetes Care. 1992 Apr;15(4):469-77 - PubMed
  32. J Med Assoc Thai. 2011 Feb;94 Suppl 1:S168-74 - PubMed
  33. Med Care. 1992 Jun;30(6):473-83 - PubMed
  34. Diabetes Care. 1994 Apr;17(4):267-74 - PubMed
  35. Health Technol Assess. 1998;2(14):i-iv, 1-74 - PubMed
  36. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 - PubMed
  37. Diabetes Care. 2004 Dec;27(12):2850-5 - PubMed
  38. Diabetes Res Clin Pract. 2001 Apr;52(1):63-71 - PubMed
  39. Diabetes Care. 1988 Oct;11(9):725-32 - PubMed
  40. Qual Life Res. 1999;8(1-2):79-91 - PubMed
  41. Obes Facts. 2011;4(4):284-9 - PubMed
  42. Health Qual Life Outcomes. 2008 Oct 28;6:87 - PubMed
  43. Diabetes Care. 1998 Sep;21(9):1414-31 - PubMed
  44. Diabetes Technol Ther. 2011 Dec;13(12):1201-6 - PubMed

Publication Types